Article

Construction of risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation

2021-10-19

Abstract excerpt

<title>Abstract</title> <p>Background Epigenetic reprogramming reportedly has a crucial role in prostate cancer (PCa) progression. RNA modification is a hot topic in epigenetics, and N6-methyladenosine (m6A) accounts for approximately 60% of RNA chemical modifications. The aim of this study was to construct risk prediction model using m6A RNA regulators in PCa. Materials and methods Analyses were based on leve...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0f9d0f1c-3d73-5af9-bbe3-c5951fdaf655
DOI: 10.21203/rs.3.rs-979251/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Construction of risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validationDOI 10.21203/rs.3.rs-979251/v1Read

Subtypes of m6A RNA Modification Defines Tumor Microenvironment, Immunotherapy and Pharmacogenomic Landscape in Prostate CancerSemantic proximity Read

m6A Methylation Regulators Are Predictive Biomarkers for Tumour Metastasis in Prostate CancerSemantic proximity Read

Prediction of Prognosis in Patients with Prostate Cancer by DNA Methylation ClassificationSemantic proximity Read

An N6-methyladenosine-Related Classification Predicts Prognosis and Response to Immunotherapy in Prostate cancerSemantic proximity Read

A Risk Prediction Model of DNA Methylation Improves Prognosis Evaluation and Indicates Gene Targets in Prostate CancerSemantic proximity Read

Prognostic Value and Possible Mechanism of m6A Methyltransferase METTL3 in Prostate CancerSemantic proximity Read

RNA modification Regulators' Co-Expression Score (RMRCoeS) predicts biochemical recurrence and therapy response in prostate cancer: A multi-omics and experimental validation study.Semantic proximity Read

Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancerSemantic proximity Read

Prognostic Value of A Risk Score Model Constructed By m6A Methylation Regulators In Breast CancerSemantic proximity Read

An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk.Semantic proximity Read

Molecular Characterization and Clinical Relevance of m6A Regulators in Metastatic Prostate CancerSemantic proximity Read

Integrative analyses of DNA methylase expression and related immune landscape in Prostate CancerSemantic proximity Read